Search | Médecins Sans Frontières Access Campaign

About us
About the Access Campaign

Our 2024 wishlist

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

Pandemic prevention, preparedness and response

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

A Fair Shot

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

Time for $5

No Patents in a Pandemic

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action

7 results found
There are 8 active filters
Clear all filters
Regional Comprehensive Economic Partnership (RCEP)
Issue brief
Letter
Statement
Technical brief

7 results found

Letter |

24 February 2017

RCEP investment chapter presents a grave threat to access to medicines

Tags Intellectual property and trade access to medicinesgeneric medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP)

Statement |

12 December 2016

MSF intervention at the 25th WIPO Standing Committee on Patents

Tags Intellectual property and trade intellectual property & tradeRegional Comprehensive Economic Partnership (RCEP)TRIPSUN High Level Panel on Access to Medicines

ReportCover_ACCESS_Brief_RCEPTradingAwayHealth_ENG_2016_0-1.jpg

Technical brief |

02 December 2016

Trading Away Health: The Regional Comprehensive Economic Partnership (RCEP)

Tags Intellectual property and trade access to medicinesdata exclusivityintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP)

Technical brief |

30 November 2016

RCEP IP chapter analysis

Tags access to medicinesgeneric medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP)

Letter |

17 October 2016

An open letter to the sixteen governments negotiating the Regional Comprehensive Economic Partnership (RCEP)

Health organisations call on trade ministers to reject provisions that would negatively affect access to generic medicines in the Regional Comprehensive Economic Partnership agreement.

Tags Intellectual property and trade access to medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP)

Issue brief |

13 June 2016

Damaging impact of two proposed TRIPS-plus measures in RCEP trade deal

Tags Intellectual property and trade intellectual property & tradeRegional Comprehensive Economic Partnership (RCEP)TRIPS New Zealand

Letter |

25 August 2014

MSF Letter to Indian government - IP negotiations in the Regional Comprehensive Economic Partnership

Tags Intellectual property and trade access to medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP) India